BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 11805286)

  • 1. Subnuclear distribution of topoisomerase I is linked to ongoing transcription and p53 status.
    Mao Y; Mehl IR; Muller MT
    Proc Natl Acad Sci U S A; 2002 Feb; 99(3):1235-40. PubMed ID: 11805286
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p53 dependence of topoisomerase I recruitment in vivo.
    Mao Y; Okada S; Chang LS; Muller MT
    Cancer Res; 2000 Aug; 60(16):4538-43. PubMed ID: 10969804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional expression of human DNA topoisomerase I and its subcellular localization in HeLa cells.
    Mo YY; Wang P; Beck WT
    Exp Cell Res; 2000 May; 256(2):480-90. PubMed ID: 10772820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel nuclear localization signal in human DNA topoisomerase I.
    Mo YY; Wang C; Beck WT
    J Biol Chem; 2000 Dec; 275(52):41107-13. PubMed ID: 11016921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human topoisomerase IIalpha and IIbeta interact with the C-terminal region of p53.
    Cowell IG; Okorokov AL; Cutts SA; Padget K; Bell M; Milner J; Austin CA
    Exp Cell Res; 2000 Feb; 255(1):86-94. PubMed ID: 10666337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of catalytic activity and nucleolar localization of rat DNA topoisomerase IIα through its C-terminal domain.
    Yasuda K; Kato Y; Ikeda S; Kawano S
    Genes Genet Syst; 2021 Mar; 95(6):291-302. PubMed ID: 33551432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of DNA topoisomerase I activity by p53.
    Gobert C; Bracco L; Rossi F; Olivier M; Tazi J; Lavelle F; Larsen AK; Riou JF
    Biochemistry; 1996 May; 35(18):5778-86. PubMed ID: 8639538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting to transcriptionally active loci by the hydrophilic N-terminal domain of Drosophila DNA topoisomerase I.
    Shaiu WL; Hsieh TS
    Mol Cell Biol; 1998 Jul; 18(7):4358-67. PubMed ID: 9632819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of a nucleolin binding site in human topoisomerase I.
    Bharti AK; Olson MO; Kufe DW; Rubin EH
    J Biol Chem; 1996 Jan; 271(4):1993-7. PubMed ID: 8567649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subnuclear Localization of Human Topoisomerase I.
    Girstun A; Ishikawa T; Kowalska-Loth B; Czubaty A; Staron K
    J Cell Biochem; 2017 Feb; 118(2):407-419. PubMed ID: 27428351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RNA synthesis inhibitors alter the subnuclear distribution of DNA topoisomerase I.
    Buckwalter CA; Lin AH; Tanizawa A; Pommier YG; Cheng YC; Kaufmann SH
    Cancer Res; 1996 Apr; 56(7):1674-81. PubMed ID: 8603419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The N-terminal domain anchors human topoisomerase I at fibrillar centers of nucleoli and nucleolar organizer regions of mitotic chromosomes.
    Christensen MO; Barthelmes HU; Boege F; Mielke C
    J Biol Chem; 2002 Sep; 277(39):35932-8. PubMed ID: 12119295
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simian virus 40 large T antigen binds to topoisomerase I.
    Simmons DT; Melendy T; Usher D; Stillman B
    Virology; 1996 Aug; 222(2):365-74. PubMed ID: 8806520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human ARF protein interacts with topoisomerase I and stimulates its activity.
    Karayan L; Riou JF; Séité P; Migeon J; Cantereau A; Larsen CJ
    Oncogene; 2001 Feb; 20(7):836-48. PubMed ID: 11314011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topoisomerase IIalpha gene expression is regulated by the p53 tumor suppressor gene in nonsmall cell lung carcinoma patients.
    Liu D; Huang CL; Kameyama K; Hayashi E; Yamauchi A; Sumitomo S; Yokomise H
    Cancer; 2002 Apr; 94(8):2239-47. PubMed ID: 12001123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Degradation of DNA topoisomerase I by a novel trypsin-like serine protease in proliferating human T lymphocytes.
    Chen HJ; Hwong CL; Wang CH; Hwang J
    J Biol Chem; 2000 Apr; 275(17):13109-17. PubMed ID: 10777616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topoisomerase I protein expression in primary colorectal cancer and lymph node metastases.
    Boonsong A; Curran S; McKay JA; Cassidy J; Murray GI; McLeod HL
    Hum Pathol; 2002 Nov; 33(11):1114-9. PubMed ID: 12454816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Delineation of the domains required for physical and functional interaction of p14ARF with human topoisomerase I.
    Ayrault O; Karayan L; Riou JF; Larsen CJ; Séité P
    Oncogene; 2003 Apr; 22(13):1945-54. PubMed ID: 12673200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The C-terminal domain but not the tyrosine 723 of human DNA topoisomerase I active site contributes to kinase activity.
    Rossi F; Labourier E; Gallouzi IE; Derancourt J; Allemand E; Divita G; Tazi J
    Nucleic Acids Res; 1998 Jun; 26(12):2963-70. PubMed ID: 9611242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacodynamics of topoisomerase I inhibition: Western blot determination of topoisomerase I and cleavable complex in patients with upper gastrointestinal malignancies treated with topotecan.
    Liebes L; Potmesil M; Kim T; Pease D; Buckley M; Fry D; Cho J; Adler H; Dar K; Zeleniuch-Jacquotte A; Hochster H
    Clin Cancer Res; 1998 Mar; 4(3):545-57. PubMed ID: 9533521
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.